The JAK/STAT pathway in rheumatoid arthritis: Pathogenic or protective?

被引：92

作者：

Ivashkiv, LB

Hu, XY

机构：

[1] Hosp Special Surg, Dept Med, New York, NY 10021 USA

[2] Cornell Univ, Weill Med Coll, New York, NY USA

来源：

ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 08期

关键词：

D O I：

10.1002/art.11095

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2092 / 2096

页数：5

共 43 条

[1] Roles of STAT3 defined by tissue-specific gene targeting [J].

Akira, S .

ONCOGENE, 2000, 19 (21) :2607-2611

[2] A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis [J].

Atsumi, T ;

Ishihara, K ;

Kamimura, D ;

Ikushima, H ;

Ohtani, T ;

Hirota, S ;

Kobayashi, H ;

Park, SJ ;

Saeki, Y ;

Kitamura, Y ;

Hirano, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) :979-990

[3] BIPHASIC EFFECT OF INTERFERON-GAMMA IN MURINE COLLAGEN-INDUCED ARTHRITIS [J].

BOISSIER, MC ;

CHIOCCHIA, G ;

BESSIS, N ;

HAJNAL, J ;

GAROTTA, G ;

NICOLETTI, F ;

FOURNIER, C .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) :1184-1190

[4] The role of STATs in transcriptional control and their impact on cellular function [J].

Bromberg, J ;

Darnell, JE .

ONCOGENE, 2000, 19 (21) :2468-2473

[5] Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis [J].

Chin, YE ;

Kitagawa, M ;

Kuida, K ;

Flavell, RA ;

Fu, XY .

MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) :5328-5337

[6] Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis - A randomized, double-blind, placebo-controlled, dose-escalation trial [J].

Choy, EHS ;

Isenberg, DA ;

Garrood, T ;

Farrow, S ;

Ioannou, Y ;

Bird, H ;

Cheung, N ;

Williams, B ;

Hazleman, B ;

Price, R ;

Yoshizaki, K ;

Nishimoto, N ;

Kishimoto, T ;

Panayi, GS .

ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3143-3150

[7]

de Hooge ASK, 2002, ARTHRITIS RHEUM-US, V46, pS250

[8] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[9] Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease [J].

Durbin, JE ;

Hackenmiller, R ;

Simon, MC ;

Levy, DE .

CELL, 1996, 84 (03) :443-450

[10] Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation [J].

Egan, PJ ;

Lawlor, KE ;

Alexander, WS ;

Wicks, IP .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (06) :915-924

← 1 2 3 4 5 →